Amp-Sulbacta 1-0.5gm Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
This medication can be administered via injection into a muscle or as an intravenous infusion over a specified period. In some cases, it may be given as a direct injection into a vein.
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Complete the full course of medication as prescribed, even if symptoms improve, to prevent antibiotic resistance and recurrence of infection.
- Report any signs of allergic reaction (rash, itching, swelling, difficulty breathing) immediately.
- Report severe or persistent diarrhea, as it could be a sign of a more serious infection (C. difficile).
- Maintain good hydration.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
In rare cases, allergic reactions can be fatal.
Antibiotic-Associated Diarrhea
Diarrhea is a common side effect of antibiotics. However, in rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) may occur. This condition can lead to life-threatening bowel problems. If you experience any of the following symptoms, contact your doctor right away:
Stomach pain
Cramps
Very loose, watery, or bloody stools
Before treating diarrhea, consult with your doctor.
Liver Problems
Rarely, this medication can cause liver problems, which can be fatal. Seek medical attention immediately if you notice any of the following symptoms:
Dark urine
Tiredness
Decreased appetite
Upset stomach or stomach pain
Light-colored stools
Vomiting
Yellow skin or eyes
Severe Skin Reactions
This medication can cause severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. These conditions can affect body organs and be life-threatening. Seek medical help right away if you experience any of the following symptoms:
Red, swollen, blistered, or peeling skin
Red or irritated eyes
Sores in your mouth, throat, nose, eyes, genitals, or any areas of skin
Fever
Chills
Body aches
Shortness of breath
Swollen glands
Other Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:
Diarrhea
Pain at the injection site (if administered via muscle injection)
Reporting Side Effects
These are not all the possible side effects that may occur. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe rash, hives, or itching
- Swelling of the face, lips, tongue, or throat
- Difficulty breathing or swallowing
- Severe or watery diarrhea, especially if bloody or with fever
- Unusual bruising or bleeding
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
- Seizures
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you are allergic to penicillin, as this may impact your ability to take this medication safely.
If you have been diagnosed with mononucleosis (mono), as this condition may affect how your body responds to the medication.
If you have experienced liver problems or jaundice (turned yellow) while taking this medication in the past, as this may indicate a sensitivity to the drug.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing health conditions and other medications. Never start, stop, or adjust the dose of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
If you have diabetes and regularly test your urine for glucose, consult with your doctor to determine the most suitable tests to use, as this medication may affect the results.
Do not take this medication for longer than prescribed, as this may increase the risk of a second infection.
If you are pregnant, planning to become pregnant, or are breastfeeding, discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
Overdose Information
Overdose Symptoms:
- Neurological toxicity (e.g., seizures, especially in patients with impaired renal function)
- Gastrointestinal disturbances (nausea, vomiting, diarrhea)
- Electrolyte imbalances
What to Do:
Treatment is largely supportive. Hemodialysis may be effective in removing ampicillin and sulbactam from the circulation in cases of severe overdose or renal impairment. Call 1-800-222-1222 (Poison Control Center) immediately.
Drug Interactions
Major Interactions
- Methotrexate: Increased methotrexate levels and toxicity due to reduced renal clearance.
- Oral Contraceptives: May reduce efficacy of oral contraceptives (though evidence is limited and controversial, advise backup contraception).
Moderate Interactions
- Allopurinol: Increased incidence of skin rash (especially in hyperuricemic patients).
- Probenecid: Decreases renal tubular secretion of ampicillin and sulbactam, resulting in increased and prolonged serum concentrations of both drugs.
- Anticoagulants (e.g., Warfarin): May alter coagulation parameters (e.g., INR) by affecting gut flora and vitamin K production, or by direct interaction (rare).
Minor Interactions
- Tetracyclines: May antagonize the bactericidal effect of ampicillin (avoid concomitant use).
Monitoring
Baseline Monitoring
Rationale: To establish baseline for dose adjustment in renal impairment and monitor for potential nephrotoxicity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline and monitor for potential hepatotoxicity, especially with prolonged therapy.
Timing: Prior to initiation of therapy
Rationale: To establish baseline and monitor for potential hematologic abnormalities (e.g., anemia, leukopenia, thrombocytopenia), especially with prolonged therapy.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically, especially in patients with pre-existing renal impairment or prolonged therapy
Target: Within patient's baseline or normal limits
Action Threshold: Significant increase from baseline or above normal range; consider dose adjustment or discontinuation.
Frequency: Periodically, especially with prolonged therapy (>2 weeks)
Target: Within normal limits
Action Threshold: Significant elevation (e.g., >3x ULN); consider discontinuation.
Frequency: Periodically, especially with prolonged therapy (>2 weeks)
Target: Within normal limits
Action Threshold: Significant decrease in cell lines (e.g., leukopenia, thrombocytopenia); consider discontinuation.
Frequency: Daily during therapy and for several weeks post-therapy
Target: Absence of new infections
Action Threshold: Presence of new or worsening symptoms; initiate appropriate treatment.
Symptom Monitoring
- Allergic reactions (rash, pruritus, urticaria, dyspnea, angioedema)
- Gastrointestinal disturbances (nausea, vomiting, diarrhea, abdominal pain)
- Signs of Clostridioides difficile-associated diarrhea (CDAD) (severe, persistent diarrhea, abdominal cramps, fever)
- Injection site reactions (pain, tenderness, induration)
- Neurological symptoms (seizures, especially with high doses in renal impairment)
Special Patient Groups
Pregnancy
Category B. Studies in animals have not shown evidence of harm to the fetus. Adequate and well-controlled studies in pregnant women are lacking, but human experience with ampicillin and other penicillins has not shown evidence of adverse effects. Use only if clearly needed.
Trimester-Specific Risks:
Lactation
Both ampicillin and sulbactam are excreted in human milk in low concentrations. Generally considered compatible with breastfeeding (L2). Monitor breastfed infant for potential adverse effects such as diarrhea, candidiasis (thrush, diaper rash), or allergic reactions (rash).
Pediatric Use
Dosing must be carefully calculated based on weight and age. Neonates and infants may have immature renal function, requiring careful monitoring and dose adjustment. Safety and efficacy in neonates have not been fully established for all indications.
Geriatric Use
No specific dose adjustment is typically needed based on age alone, but elderly patients are more likely to have decreased renal function, which necessitates dose adjustment based on creatinine clearance. Monitor for adverse effects and superinfections.
Clinical Information
Clinical Pearls
- Ampicillin/sulbactam is a broad-spectrum antibiotic effective against many Gram-positive, Gram-negative, and anaerobic bacteria, including many beta-lactamase producing strains.
- It is commonly used for polymicrobial infections, such as intra-abdominal infections, gynecological infections, and skin and soft tissue infections.
- Administer IV doses slowly over 15-30 minutes to minimize injection site reactions and potential for seizures with rapid infusion.
- Reconstituted solutions should be used promptly; stability varies by diluent and concentration.
- Patients with a history of penicillin allergy should be carefully assessed; cross-reactivity with cephalosporins is possible but low (approx. 1-5%).
- Monitor for C. difficile-associated diarrhea, which can occur during or even weeks after antibiotic therapy.
Alternative Therapies
- Carbapenems (e.g., Imipenem/Cilastatin, Meropenem, Ertapenem) for broader spectrum or resistant infections
- Cephalosporins (e.g., Cefoxitin, Cefotetan, Ceftriaxone + Metronidazole for anaerobes)
- Fluoroquinolones (e.g., Moxifloxacin, Ciprofloxacin + Metronidazole)
- Metronidazole (for anaerobic coverage when combined with other agents)
- Clindamycin (for anaerobic and some Gram-positive coverage)